JP2024507693A5 - - Google Patents

Info

Publication number
JP2024507693A5
JP2024507693A5 JP2023545974A JP2023545974A JP2024507693A5 JP 2024507693 A5 JP2024507693 A5 JP 2024507693A5 JP 2023545974 A JP2023545974 A JP 2023545974A JP 2023545974 A JP2023545974 A JP 2023545974A JP 2024507693 A5 JP2024507693 A5 JP 2024507693A5
Authority
JP
Japan
Prior art keywords
antigen
amino acid
terminus
bispecific antibody
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023545974A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507693A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/074133 external-priority patent/WO2022166728A1/zh
Publication of JP2024507693A publication Critical patent/JP2024507693A/ja
Publication of JP2024507693A5 publication Critical patent/JP2024507693A5/ja
Pending legal-status Critical Current

Links

JP2023545974A 2021-02-07 2022-01-27 二重特異性抗体 Pending JP2024507693A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202110178932 2021-02-07
CN202110178932.5 2021-02-07
CN202110937430.6 2021-08-16
CN202110937430 2021-08-16
PCT/CN2022/074133 WO2022166728A1 (zh) 2021-02-07 2022-01-27 双特异性抗体

Publications (2)

Publication Number Publication Date
JP2024507693A JP2024507693A (ja) 2024-02-21
JP2024507693A5 true JP2024507693A5 (cg-RX-API-DMAC7.html) 2025-02-03

Family

ID=82740913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023545974A Pending JP2024507693A (ja) 2021-02-07 2022-01-27 二重特異性抗体

Country Status (12)

Country Link
US (1) US20240092899A1 (cg-RX-API-DMAC7.html)
EP (1) EP4303231A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024507693A (cg-RX-API-DMAC7.html)
KR (1) KR20230141817A (cg-RX-API-DMAC7.html)
CN (2) CN116964084A (cg-RX-API-DMAC7.html)
AU (1) AU2022215712A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023015217A2 (cg-RX-API-DMAC7.html)
CA (1) CA3210307A1 (cg-RX-API-DMAC7.html)
IL (1) IL304800A (cg-RX-API-DMAC7.html)
MX (1) MX2023008966A (cg-RX-API-DMAC7.html)
TW (1) TW202233694A (cg-RX-API-DMAC7.html)
WO (1) WO2022166728A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7734075B2 (ja) * 2018-12-24 2025-09-04 サノフイ 疑似fabベースの多重特異性結合タンパク質
TW202321312A (zh) * 2021-09-08 2023-06-01 俄羅斯聯邦商拜奧卡德聯合股份公司 包含基於mhc或mhc樣蛋白的異源二聚體的二價雙特異性嵌合抗體
CN118076644A (zh) * 2021-09-30 2024-05-24 正大天晴药业集团股份有限公司 针对免疫检查点的双特异性抗体
US20260209385A1 (en) * 2022-12-08 2026-07-23 Analytical Biosciences Shanghai Limited Bispecific/multi-specific antibodies and uses thereof
WO2025213057A1 (en) * 2024-04-04 2025-10-09 Fletcher Biosciences, Inc. Engineered major histocompatibility complex molecules and uses thereof
WO2026061376A1 (zh) * 2024-09-18 2026-03-26 映恩生物科技(上海)有限公司 新型双特异性多肽复合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2558811A1 (en) * 2004-03-08 2005-09-22 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
JP6475167B2 (ja) * 2012-12-21 2019-02-27 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ジスルフィド結合した多価mhcクラスiを含む多機能タンパク質
SG10201901057UA (en) 2014-08-05 2019-03-28 Cb Therapeutics Inc Anti-pd-l1 antibodies
WO2017151940A2 (en) * 2016-03-03 2017-09-08 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
CN111094333A (zh) * 2017-06-01 2020-05-01 斯图加特大学 异源二聚化的Ig结构域
AU2018290272A1 (en) * 2017-06-21 2020-01-30 Gsbio, Llc Heterodimeric bispecific antibodies
CN109422811A (zh) 2017-08-29 2019-03-05 信达生物制药(苏州)有限公司 抗cd47抗体及其用途
CN117843810A (zh) * 2017-09-22 2024-04-09 上海药明生物技术有限公司 新型双特异性多肽复合物
WO2019179627A1 (en) * 2018-03-22 2019-09-26 Universität Stuttgart Multivalent binding molecules
KR20200142525A (ko) 2018-04-05 2020-12-22 노파르티스 아게 암에 대한 삼중특이성 결합 분자 및 이의 용도
CN112384243A (zh) * 2018-04-17 2021-02-19 英温拉公司 三价三特异性抗体构建体
JP2022536581A (ja) * 2019-06-19 2022-08-18 キュー バイオファーマ, インコーポレイテッド 多量体t細胞調節性ポリペプチド及びその使用方法

Similar Documents

Publication Publication Date Title
US10982008B2 (en) Domain-exchanged antibody
EP4303231A1 (en) Bispecific antibody
JP7600327B2 (ja) Pd-1とvegfを標的とした四価二重特異性抗体、その製造方法および用途
JP2016093175A (ja) 静電的ステアリング(electrostaticsteering)効果を用いた抗体Fcヘテロ二量体分子を作製するための方法
WO2014014796A1 (en) Multi-specific igg-(fab)2 constructs containing t-cell receptor constant domains
CN110382537B (zh) 抗体结构域的优选配对
WO2021188736A1 (en) MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF
CA3149350A1 (en) Igm glycovariants
JP2021500873A (ja) システイン操作された抗原結合分子
TWI918721B (zh) Egfr結合複合物及其製備和使用方法
TW202346337A (zh) Ilt3及cd3結合劑以及其使用方法
KR20260010770A (ko) 항-cd28 × 항-trop2 항체
EP4469478A1 (en) Bispecific molecule with tunable affinity to a targetted antigen
CN120344558A (zh) 双特异性/多特异性抗体及其用途
EA051713B1 (ru) Биспецифическое антитело
JP2025528101A (ja) 多重特異性ポリペプチド複合体
WO2025250941A1 (en) Cμ4 REGION FOR PAIRING HEAVY AND LIGHT CHAINS IN MULTI-SPECIFIC ANTIBODIES
EA041608B1 (ru) Гетеродимерный полиспецифичный формат антител